Clinical Trial Update: Cyclophosphamide, Autologous Lymphocytes, and Aldesleukin in Treating Patients With Metastatic Melanoma

View source ↗

Summary

The clinical trial investigating cyclophosphamide, autologous lymphocytes, and aldesleukin for metastatic melanoma is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Autologous lymphocytes (Autologous lymphocytes)
• Cytoxan (cyclophosphamide)
• Proleukin (aldesleukin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Melanoma (Skin) | Status: NO_LONGER_AVAILABLE